← All companies
AQST
Aquestive Therapeutics, Inc.
$3.79
+0.07 +1.88%
Key statistics
from XBRL data in SEC filingsMarket cap
$475M
Revenue (TTM)
$50.3M
Net income (TTM)
-$68.9M
EPS (TTM)
$-0.61
P/E ratio
—
Dividend yield
—
Free cash flow
-$53.0M
Cash
$111M
Total assets
$141M
Gross margin
—
52-week range
$2.93 – $7.55
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Shareholder vote results
Jun 10, 2026
10-Q
Quarter ended 2026-03-31
May 13, 2026
8-K
Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure
May 13, 2026
8-K
Regulation FD disclosure
Mar 30, 2026
8-K
Director or officer change; Regulation FD disclosure
Mar 20, 2026
10-K
Fiscal year ended 2025-12-31
Mar 4, 2026
8-K
Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure
Mar 4, 2026
8-K
Regulation FD disclosure
Feb 26, 2026
8-K
Regulation FD disclosure
Feb 2, 2026
8-K
Other events
Jan 9, 2026
8-K
Regulation FD disclosure
Nov 6, 2025
10-Q
Quarter ended 2025-09-30
Nov 5, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 5, 2025
8-K
Other events
Oct 8, 2025
8-K
Regulation FD disclosure
Oct 1, 2025
8-K
Regulation FD disclosure
Sep 8, 2025
8-K
Regulation FD disclosure
Sep 4, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Aug 15, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Aug 14, 2025
10-Q
Quarter ended 2025-06-30
Aug 11, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 11, 2025
8-K
Other events
Jul 15, 2025
8-K
Regulation FD disclosure
Jun 16, 2025
8-K
Shareholder vote results
Jun 11, 2025
8-K
Regulation FD disclosure
Jun 2, 2025
10-Q
Quarter ended 2025-03-31
May 12, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 12, 2025
8-K
Regulation FD disclosure
Apr 1, 2025
8-K
Regulation FD disclosure
Mar 10, 2025
10-K
Fiscal year ended 2024-12-31
Mar 5, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 5, 2025
8-K
Other events
Feb 12, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 13, 2025
8-K
Other events
Dec 19, 2024
8-K
Regulation FD disclosure; Other events
Dec 2, 2024
8-K
Director or officer change
Nov 7, 2024
8-K
Regulation FD disclosure
Nov 6, 2024
10-Q
Quarter ended 2024-09-30
Nov 4, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 4, 2024
8-K
Other events
Oct 25, 2024